CFI-400945 and Durvalumab in Patients With Advanced Triple Negative Breast Cancer
Clinical trial NCT04176848 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04176848
- Sponsor
- Canadian Cancer Trials Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-10
- Primary completion
- 2022-09-15
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.